rs199873582
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM5
The NM_019892.6(INPP5E):c.875G>A(p.Arg292His) variant causes a missense change. The variant allele was found at a frequency of 0.000258 in 1,612,102 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R292G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_019892.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPP5E | NM_019892.6 | c.875G>A | p.Arg292His | missense_variant | 2/10 | ENST00000371712.4 | NP_063945.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712.4 | c.875G>A | p.Arg292His | missense_variant | 2/10 | 1 | NM_019892.6 | ENSP00000360777.3 | ||
INPP5E | ENST00000676019.1 | c.875G>A | p.Arg292His | missense_variant | 2/10 | ENSP00000501984.1 | ||||
INPP5E | ENST00000675256.1 | c.62G>A | p.Arg21His | missense_variant | 1/2 | ENSP00000502517.1 | ||||
INPP5E | ENST00000674513.1 | n.146G>A | non_coding_transcript_exon_variant | 2/3 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000285 AC: 70AN: 245666Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 133960
GnomAD4 exome AF: 0.000258 AC: 377AN: 1459798Hom.: 1 Cov.: 38 AF XY: 0.000286 AC XY: 208AN XY: 726122
GnomAD4 genome AF: 0.000256 AC: 39AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 14, 2024 | Variant summary: INPP5E c.875G>A (p.Arg292His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 245666 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in INPP5E causing Joubert Syndrome And Related Disorders (0.00028 vs 0.00079), allowing no conclusion about variant significance. c.875G>A has been reported in a heterozygous individual diagnosed with ataxia (Sun_2019). This report does not provide unequivocal conclusions about association of the variant with Joubert Syndrome And Related Disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 29915382). ClinVar contains an entry for this variant (Variation ID: 211185). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 26, 2015 | - - |
Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 292 of the INPP5E protein (p.Arg292His). This variant is present in population databases (rs199873582, gnomAD 0.07%). This missense change has been observed in individuals with INPP5E-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 211185). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on INPP5E protein function. This variant disrupts the p.Arg292 amino acid residue in INPP5E. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28559085; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
INPP5E-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 09, 2024 | The INPP5E c.875G>A variant is predicted to result in the amino acid substitution p.Arg292His. This variant was reported in the heterozygous state in a patient with ataxia and molar tooth sign with additional clinical features (Patient 036 in Sun et al. 2019. PubMed ID: 29915382). However, a second variant was not reported in this patient, and further evidence was not provided to support pathogenicity. A different variant affecting the same amino acid (p.Arg292Gly) along with a second variant in this gene was reported to be associated with autosomal recessive retinal disease (Table S4, Stone et al. 2017. PubMed ID: 28559085). The c.875G>A (p.Arg292His) variant is reported in 0.071% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | The c.875G>A (p.R292H) alteration is located in exon 2 (coding exon 2) of the INPP5E gene. This alteration results from a G to A substitution at nucleotide position 875, causing the arginine (R) at amino acid position 292 to be replaced by a histidine (H). The in silico prediction for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Joubert syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at